InvestorsHub Logo
Followers 0
Posts 83
Boards Moderated 0
Alias Born 05/13/2016

Re: ignatiusrielly35 post# 33375

Tuesday, 09/12/2017 8:29:41 PM

Tuesday, September 12, 2017 8:29:41 PM

Post# of 108192
Hi Reilly, I really cannot fathom any reason for a tute to outright short against their own long shares. Loan em all out and collect interest, yes, but shorting? What's the point? Something to do with shaking warrants loose?

On another topic, I also suspected from the PR that HER2 is on the block for sale or license (hand-off to MRK or AZN to move present efforts forward?). However, mpreorder's response to this idea was that ADXS dropped these due to poor data that I must have missed. To me, HER2 seems the best dressed and most separable franchise to sell off at this time. Proving out in canine via PETX (soon I hope), already had planned PhaseII with Childrens Oncology Group (candidate for IST), and MRK already with a site-agnostic HER2- approval.

Best to you!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News